DK0952982T3 - Hidtil ukendte hepatitis B inhibitorer - Google Patents

Hidtil ukendte hepatitis B inhibitorer

Info

Publication number
DK0952982T3
DK0952982T3 DK97946476T DK97946476T DK0952982T3 DK 0952982 T3 DK0952982 T3 DK 0952982T3 DK 97946476 T DK97946476 T DK 97946476T DK 97946476 T DK97946476 T DK 97946476T DK 0952982 T3 DK0952982 T3 DK 0952982T3
Authority
DK
Denmark
Prior art keywords
inhibitors
new hepatitis
hepatitis
new
peptides
Prior art date
Application number
DK97946476T
Other languages
English (en)
Inventor
Kenneth Murray
Richard Dyson Michael
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Inc filed Critical Biogen Inc
Application granted granted Critical
Publication of DK0952982T3 publication Critical patent/DK0952982T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK97946476T 1996-10-31 1997-10-31 Hidtil ukendte hepatitis B inhibitorer DK0952982T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3053496P 1996-10-31 1996-10-31
PCT/US1997/019965 WO1998018818A2 (en) 1996-10-31 1997-10-31 Hepatitis b inhibitors

Publications (1)

Publication Number Publication Date
DK0952982T3 true DK0952982T3 (da) 2004-03-29

Family

ID=21854673

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97946476T DK0952982T3 (da) 1996-10-31 1997-10-31 Hidtil ukendte hepatitis B inhibitorer

Country Status (11)

Country Link
US (1) US6544520B1 (da)
EP (1) EP0952982B1 (da)
JP (2) JP4091663B2 (da)
AT (1) ATE255594T1 (da)
AU (1) AU5163598A (da)
CA (1) CA2270401A1 (da)
DE (1) DE69726602T2 (da)
DK (1) DK0952982T3 (da)
ES (1) ES2207753T3 (da)
PT (1) PT952982E (da)
WO (1) WO1998018818A2 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA004497B1 (ru) * 1998-12-04 2004-04-29 Байоджен, Инк. Коровые антигенные частицы hbv с множественными иммуногенными компонентами, связанными посредством пептидных лигандов
KR100746991B1 (ko) 2004-08-06 2007-08-08 한국과학기술연구원 Ｈｂｖ 코아 단백질과 표면 단백질 간 상호작용의 측정을이용한 ｈｂｖ의 증식 억제물질의 검색방법
KR100949310B1 (ko) * 2007-11-21 2010-03-23 한국과학기술연구원 세포 영상 기법을 이용한 ｈｂｖ 캡시드 단백질과 표면단백질 간 상호작용 측정 방법과 이를 이용한 ｈｂｖ 증식억제물질의 검색방법
CN101503461B (zh) * 2009-02-12 2011-09-07 北京大学人民医院 一种具有诱导肝癌细胞凋亡功能的多肽
EP4651762A1 (en) 2023-01-19 2025-11-26 SharkNinja Operating LLC Hair care appliance with powered attachment
US20240245190A1 (en) 2023-01-19 2024-07-25 Sharkninja Operating Llc Identification of hair care appliance attachments

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204096A (en) 1984-03-07 1993-04-20 New York Blood Center, Inc. Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
US5296572A (en) 1986-04-30 1994-03-22 James Sparrow Large pore polyamide resin and method of preparation thereof
ES2061500T5 (es) 1986-06-17 2003-05-16 Chiron Corp Diagnosis y vacunas de la hepatitis delta, su preparacion y uso.
JPH02273700A (ja) 1989-04-14 1990-11-08 Olympus Optical Co Ltd ペプチド
US5547669A (en) 1989-11-03 1996-08-20 Immulogic Pharma Corp Recombinant peptides comprising T cell epitopes of the cat allergen, Fel d I
KR940000755B1 (ko) 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드
US5556744A (en) 1992-05-29 1996-09-17 The Trustees Of The University Of Pennsylvania Methods and compositions for diagnosing and treating certain HIV infected patients
US5531990A (en) 1993-12-15 1996-07-02 Health Research, Inc. Method of raising an immune response with an anti-idiotypic antibody having correspondence with human hepatitis B surface antigen
US5856459A (en) 1995-06-06 1999-01-05 Hybridon, Inc. Oligonucleotides specific for hepatitis B virus

Also Published As

Publication number Publication date
AU5163598A (en) 1998-05-22
EP0952982B1 (en) 2003-12-03
PT952982E (pt) 2004-03-31
ES2207753T3 (es) 2004-06-01
JP2008120814A (ja) 2008-05-29
WO1998018818A3 (en) 1998-07-09
JP4091663B2 (ja) 2008-05-28
WO1998018818A2 (en) 1998-05-07
CA2270401A1 (en) 1998-05-07
US6544520B1 (en) 2003-04-08
DE69726602D1 (en) 2004-01-15
JP2001503750A (ja) 2001-03-21
EP0952982A2 (en) 1999-11-03
ATE255594T1 (de) 2003-12-15
DE69726602T2 (de) 2004-09-30

Similar Documents

Publication Publication Date Title
EA199801031A1 (ru) Ингибиторы протеинфарнезилтрансферазы
CY1106156T1 (el) Νεα χρηση βουδεσονιδης και φορμοτepολης
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
ATE270557T1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
EP1019365A4 (en) NOVEL NEGATIVELY LOADED MOLECULE DELIVERY COMPOSITIONS
DE60010098D1 (de) 28-epirapaloge
ES2195970T3 (es) L-ribavirina y usos de la misma.
TR199802676A2 (xx) T�m�rlerin, t�m�rle ilgili hastal�klar�n ve ka�eksinin tedavisi ve �nlenmesi i�in y�ntem.
ATE413386T1 (de) Ppar-gamma modulatoren
ATE368054T1 (de) Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität
TR200100922T2 (tr) Aktif maddelerin akciğerler yolu ile tatbik edilmesi.
DK0960127T3 (da) Isoleret dimert fibroblastaktiverende protein-alfa og anvendelser deraf
EA199900621A1 (ru) Лечение рассеянного склероза путем приема внутрь или ингаляции сополимера-1
DE69905170T2 (de) Thiazolopyrimidinderivate
EA200000196A1 (ru) Универсальная плазма крови
DE69533704D1 (de) Bradykinin-antagonist peptide mit n-substituierten glycinen
BG99177A (bg) Нови 7 бета-заместени-4-аза-5 алфа-холестанони като инхибитори на 5 алфа-редуктаза
ATE398630T1 (de) Zyklische conotoxin-peptide
DE69616074D1 (de) Ara-c derivate
DK0952982T3 (da) Hidtil ukendte hepatitis B inhibitorer
EA200000520A1 (ru) 2-АРИЛ-3-АРОИЛБЕНЗО[b]ТИОФЕНЫ, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ СИНДРОМА ЭСТРОГЕННОЙ НЕДОСТАТОЧНОСТИ
BG100248A (bg) Инхибитори на скваленсинтетаза
MX9602718A (es) Hidrofluoroalcanos como solventes de limpieza y desengrasado.
NO981019L (no) Deodoriserende preparater inneholdende kationiske biopolymerer, aluminiumklorhydrat og esteraseinhibitorer
ATE385805T1 (de) Neue peptide